Biology of Sport
eISSN: 2083-1862
ISSN: 0860-021X
Biology of Sport
Current Issue Manuscripts accepted About the journal Editorial board Abstracting and indexing Archive Ethical standards and procedures Contact Instructions for authors Journal's Reviewers Special Information
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2024
vol. 41
 
Share:
Share:
Short communication

Snus use in football: the threat of a new addiction?

Daniel Read
1
,
Sarah Carter
2
,
Phil Hopley
3
,
Karim Chamari
4
,
Lee Taylor
5, 6, 7

  1. Institute for Sport Business, Loughborough University London, London, United Kingdom
  2. Faculty of Health, Exercise and Sports Science, Charles Darwin University, Darwin, NT 0810, Australia
  3. Cognacity Wellbeing, London, United Kingdom
  4. Aspetar Sports Medicine and Orthopedic Hospital, FIFA Medical Centre of Excellence, Doha, Qatar
  5. School of Sport, Exercise and Health Sciences, Loughborough University. National Centre for Sport and Exercise, Medicine (NCSEM), Loughborough, United Kingdom
  6. Sport and Exercise Discipline Group, Faculty of Health, University of Technology Sydney, Moore Park, NSW, Australia
  7. Human Performance Research Centre, University of Technology Sydney (UTS), Sydney, Australia
Biol Sport. 2024;41(1):201–205
Online publish date: 2023/07/24
Article file
- 18_03439_Article.pdf  [2.76 MB]
Get citation
 
PlumX metrics:
 

INTRODUCTION

High performance expectations, employment insecurity, fatigue, injury, frequent travel, and intense media scrutiny are hallmark stressors of the professional men’s football environment conducive to mental health issues [1]. Equally, strong socio-cultural and experiential barriers exist in football that often prevent players from seeking psychological help [2]. Accordingly, the prevalence of stress and mental health problems in male professional footballers (e.g., anxiety, distress, depression) are considerable, mirroring rates in the general population including mild to severe presentation [1]. Athletes may turn to a range of mood-altering substances such as alcohol, cigarettes, cannabis, and/or painkillers used recreationally to cope with the mental load/stress of a sporting career [3]. Mood-altering substances often negatively influence well-being [4], for example, cannabis use is becoming recognised as a modifiable risk factor for several adverse effects on human health, including mental illness [5].

Snus use is common in professional male football players, attracting negative attention from practitioners, clinicians and the popular press [610]. It is an oral, smokeless tobacco product containing nicotine that is placed between the gum and upper lip. Player testimony alongside journalistic investigations confirm Snus is predominantly used recreationally to relax [8, 1012] and like smoking, is a substance commonly used to regulate mood [13]. However, whether Snus negatively affects player health or performance is not well established.

We provide a summary of the health and performance effects of Snus and nicotine, arguing that Snus use should not be considered an independent behaviour. Rather, a response to significant football-specific occupational stress warranting an interdisciplinary approach to reduce its widespread use, yet poorly understood effects, on player health and performance.

Is Snus legal?

Snus is not prohibited by the World Anti-Doping Agency (WADA) as a performance enhancing substance or controlled substance. Nicotine is however, on the WADA 2023 Monitoring Programme for in-competition use as a stimulant. Nicotine primarily acts as a neuroregulatory agent on neuronal nicotinic acetylcholine receptors in the central and peripheral nervous system, releasing dopamine via the mesolimbic pathway [14]. It has stimulatory effects in lower doses whilst depressing the central nervous system in higher doses leading to feelings of relaxation [15]. Analysis of 60,802 in-competition antidoping urine samples taken in Italy from 2012–2020 reported that on average, 22.7% (15.2–32.5%) of all samples indicated nicotine intake, increasing to 29% (18.4–40.4%) in football [16]. The nicotine content in commercially available pouched Snus from Europe is comparable to a cigarette (approx. 15mg per product) [17]. However, it leads to significantly higher plasma nicotine concentration than smoking due to the longer use duration [17]. The nicotine content and carcinogen content of Snus products varies considerably between products [18]. Indeed, Swedish Snus has greater levels of unionized nicotine in comparison to US products meaning nicotine can be absorbed quicker across mucous membranes leading to a ‘greater nicotine reward’ [19].

It is not illegal to possess or consume Snus in the UK, but it is illegal to sell. Player testimonies suggest that purchasing Snus online through social media and illegal websites or from other players is common. This raises questions about substance propriety (e.g., contaminated products that may trigger anti-doping rule violations) alongside legal and employment implications for any players caught selling Snus to teammates [7]. Ultimately, whilst nicotine remains legal from an anti-doping perspective, there is no policy incentive for players to change their behaviour. Instead, Snus use should be treated as a matter of professionalism, like alcohol and smoking, with concern concentrated on player health and team performance.

Does Snus Impact Performance or Recovery?

A recent review of the limited studies concerning oral nicotine and Snus use in sport concluded that performance enhancement was unlikely and performance may even diminish [6]. A broader review of nicotine’s impact on performance (aerobic, anaerobic and muscular) also concluded that ergogenic effects were unlikely, however, the available evidence quality for this conclusion was low [20]. Opposingly, meta-analytical findings support that nicotine can enhance some cognitive abilities on tasks involving fine motor skills, attention, and memory [21]. Further, the calming effects of high-dose nicotine described by users may offer short-term protection against the impact of stress on performance. Although, determining the impact of nicotine on performance is complex and often confounded by sampling of nicotine in naïve and chronic user participants. Indirectly, nicotine use is associated with sleep impairment [22] and the deleterious effects of limited sleep on athletic performance and recovery are well documented [23]. Equally, nicotine can lead to increased metabolic energy expenditure, reduced body weight, and appetite suppression [24] meaning Snus use may challenge optimal nutritional support for athletic performance and recovery. Therefore, chronic Snus use has the potential to undermine performance/recovery via impaired sleep and potentially diet.

Does Snus Impact Health?

Snus use has been associated with noteworthy short and long-term physiological health risks [6] linked to nicotine consumption (see Figure 1) including: (i) increased risk of periodontal disease; (ii) heat intolerance; (iii) impaired cardiovascular function; (iv) metabolic syndrome; and (v) increased mortality rates, caveated with the need for more robust studies in sport-specific populations. More broadly, meta-analytical results from military training studies indicate an association between smoking and increased injury risk [25] but there is little evidence to comment on any relationship between smokeless tobacco products, like Snus, and injury rates in high-performance athletic populations. Nicotine is a highly addictive compound and anecdotal reports suggest that dependence is becoming more common in football [8]. Like other addictions, nicotine dependence is associated with mental health issues and may lead to adverse physical and psychological withdrawal symptoms [26]. For example, short-term abstinence from nicotine can lead to intensified moodrelated symptoms including anxiety and depression [27]. On balance, using Snus as a stress-coping method has the potential to cause social, physical, and mental harm undermining players’ performance and recovery.

FIG. 1

Understanding the psychological and health impacts of Snus use in football. Please see commentary for the full reference list.

/f/fulltexts/BS/51148/JBS-41-51148-g001_min.jpg

Reducing Snus Use

A central premise of this manuscript is that Snus use can be viewed as a maladaptive stress management strategy for football-related occupational stress. Smoking cessation, appetite suppression, and pre-match psychological reassurance have been cited as motivations for Snus use. Yet anecdotally the most frequently stated reason is for recreational relaxation as shown in Figure 1, aligning with research examining smokeless tobacco users in sporting samples [28] and Snus use in the general public [13].

Paradoxically, Snus use may enhance the risk of poor performance, injury and ill-health, a significant stressor for professional athletes. Yet instigating changes towards more positive health behaviours in athletes remains difficult and education alone is often insufficient [29]. In practice, an interdisciplinary approach that not only provides information concerning health risks but situates Snus use within broader strategies to improve athlete mental well-being is required. For example, psychologists can help footballers to cope with underlying mental health status and sport specific stressors by understanding player history, peer-pressure, social supports, motivation for use, and providing evidence-based interventions (e.g., cognitive behavioural therapy). It is important that when discussing Snus use and potential cessation strategies that conversation is framed against factors valued by players to promote engagement, such as any potential negative impact on their performance. Likewise, routine enquiry and education by medical staff, identification of at-risk players through daily well-being reporting by staff with frequent interaction (e.g., physiotherapists, S&C staff), and monitored pharmacotherapy for nicotine dependence, could all contribute to identifying, preventing, reducing, and hopefully stopping Snus use. Lastly, given that occupational stressors are inherent in a professional football career, ongoing work to promote mental health awareness and reduce barriers to seeking mental health support may encourage more adaptive methods for coping with stress at an individual and club level [30].

CONCLUSIONS

Recognising the inherent data limitations, the illustrative player testimonies presented in Figure 1 support a call for more research and systematic reviews examining Snus use in elite sport. We outline six future research avenues that could develop our understanding of

Snus use in football and other elite sporting populations as well as assisting sport medicine practitioners working with athletes. First, dedicated qualitative and quantitative analysis voicing the experience and motivations of Snus use in footballers that encompasses non-users to daily users should be prioritised to theorise behaviour and understand how to design behavioural interventions. Second, comprehensive prevalence surveys should be employed to accurately establish Snus use prevalence and patterns (e.g., when and how much is used). Third, as previously mentioned, the impact of nicotine use on performance is complicated warranting further studies into the impact of Snus use on physiological, cognitive, and match performance in elite samples [31]. Fourth, an objective focus on the wellbeing impacts of Snus use and dependence are essential. At present, there is scant evidence on the long-term consequences of Snus use in elite sporting populations to properly assess the behavioural risk. Epidemiological studies should therefore be undertaken to assess lifelong outcomes that include current and retired players. Fifth, staff experiences of athlete Snus use should be canvassed to ascertain field experience to guide research [32]. Finally, rigorously designed, long-term intervention studies utilising different psychological techniques can build an evidence base to support practitioners in reducing use. All of the above would inform policies and protocols for clinical decision-making aiming at supporting holistically healthy footballers.

Disclosure of Competing Interests

All authors declare that they have no competing interests.

Contributorship

All authors significantly contributed to the commentary and approved the final version. Research and manuscript drafting was collaboratively undertaken by all authors. SC produced the infographic.

Funding, Grant and Award information

No funding was received to assist with the preparation of this manuscript.

REFERENCES

1 

Sarmento H, Frontini R, Marques A, et al. Depressive symptoms and burnout in football players: a systematic review. Brain Sci 2021; 11:1351.

2 

Confectioner K, Currie A, Gabana N, et al. Help-seeking behaviours related to mental health symptoms in professional football. BMJ Open Sport Exerc Med 2021; 7:e001070. doi:10.1136/bmjsem-2021-001070

3 

McDuff D, Stull T, Castaldelli-Maia JM, et al. Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review. Br J Sports Med 2019; 53:754–60. doi:10.1136/bjsports-2019-100669

4 

Stellern J, Xiao KB, Grennell E, et al. Emotion regulation in substance use disorders: a systematic review and meta-analysis. Addiction 2023; 118:30–47. doi:10.1111/add.16001

5 

National Academies of Sciences, Engineering and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. National Academies Press 2017.

6 

Kasper AM, Close GL. Practitioner observations of oral nicotine use in elite sport: You snus you lose. Eur J Sport Sci 2021; 21:1693–8. doi:10.1080/17461391.2020.1859621

7 

Keegan M. THE DRUG THAT IS SWAMPING FOOTBALL: Sportsmail reveal use of “snus.” Mail Online. 2018. http://www.dailymail.co.uk/sport/football/article-5559923/THE-DRUG-SWAMPING-FOOTBALL-Sportsmail-investigation-reveals-use-banned-stimulant-snus.html (accessed 13 Sep 2022).

8 

Barclay T. Addicition Worry. The Sun. 2021. https://www.thesun.co.uk/sport/football/15896680/snus-addiction-fears-english-football/ (accessed 30 Jan 2023).

9 

Frost S. Joey Barton rages at Bristol Rovers’ ‘fake footballers’ and highlights chewing tobacco use – Bristol Live. 2021. https://www.bristolpost.co.uk/sport/football/football-news/joey-barton-rages-bristol-rovers-5323046 (accessed 13 Sep 2022).

10 

Taylor D. How English football got hooked on snus: “Players don’t understand the threat of it.” The Athletic. https://theathletic.com/4347316/2023/03/30/premier-league-snus-players-addiction/ (accessed 2 May 2023).

11 

Forrester R. Snus ban is lawful after investigation into “poison” tobacco sweeping English football. The Sun. 2018. https://www.thesun.co.uk/sport/football/6044235/snus-ban-is-lawful-confirms-european-union-after-investigation-into-poison-tobacco-product-sweeping-english-football/(accessed 30 Jan 2023).

12 

Charlesworth R. Sunderland boss Lee Johnson worried over “dangerous” use of snus in football. mirror. 2021. https://www.mirror.co.uk/sport/football/news/dangerous-increasing-use-snus-football-25162507 (accessed 30 Jan 2023).

13 

Lund L, Bast LS, Rubæk M, et al. Exploring factors associated with smokeless tobacco use among young people: A systematic scoping review. Drug Alcohol Depend 2022; 240:109627. doi:10.1016/j.drugalcdep.2022.109627

14 

Laviolette SR, Van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci 5:55–65. Nat Rev Neurosci 2004; 5:55–65. doi:10.1038/nrn1298

15 

Silvette H, Hoff EC, Larson PS, et al. The Actions of Nicotine on Central Nervous System Functions. Pharmacol Rev 1962; 14:137–73.

16 

Zandonai T, Botrè F, Abate MG, et al. Should We be Concerned with Nicotine in Sport? Analysis from 60,802 Doping Control Tests in Italy. Sports Med 2023; 53:1273–9.

17 

Digard H, Proctor C, Kulasekaran A, et al. Determination of Nicotine Absorption from Multiple Tobacco Products and Nicotine Gum. Nicotine Tob Res 2013; 15:255–61. doi:10.1093/ntr/nts123

18 

Lawler TS, Stanfill SB, Tran HT, et al. Chemical analysis of snus products from the United States and northern Europe. PLoS ONE 2020; 15:e0227837. doi:10.1371/journal.pone.0227837

19 

Seidenberg AB, Ayo-Yusuf OA, Rees VW. Characteristics of “American Snus” and Swedish Snus Products for Sale in Massachusetts, USA. Nicotine Tob Res 2018; 20:262–6. doi:10.1093/ntr/ntw334

20 

Mündel T. Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations. Sports Med 2017; 47:2497–506. doi:10.1007/s40279-017-0764-5

21 

Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 2010; 210:453–69. doi:10.1007/s00213-010-1848-1

22 

Jaehne A, Loessl B, Bárkai Z, et al. Effects of nicotine on sleep during consumption, withdrawal and replacement therapy. Sleep Med Rev 2009; 13:363–77. doi:10.1016/j.smrv.2008.12.003

23 

Craven J, McCartney D, Desbrow B, et al. Effects of acute sleep loss on physical performance: a systematic and meta-analytical review. Sports Med 2022; 52:2669–90.

24 

Audrain-McGovern J, Benowitz N. Cigarette Smoking, Nicotine, and Body Weight. Clin Pharmacol Ther 2011; 90:164–8. doi:10.1038/clpt.2011.105

25 

Bedno SA, Jackson R, Feng X, et al. Meta-analysis of Cigarette Smoking and Musculoskeletal Injuries in Military Training. Med Sci Sports Exerc 2017; 49:2191–7.

26 

McLaughlin I, Dani JA, De Biasi M. Nicotine Withdrawal. Curr Top Behav Neurosci 2015; 24:99–123. doi:10.1007/978-3-319-13482-6_4

27 

Morrell HER, Cohen LM, al’Absi M. Physiological and psychological symptoms and predictors in early nicotine withdrawal. Pharmacol Biochem Behav 2008; 89:272–8. doi:10.1016/j.pbb.2007.12.020

28 

Severson HH. Smokeless tobacco use among professional baseball players: survey results, 1998 to 2003. Tob Control 2005; 14:31–6. doi:10.1136/tc.2004.007781

29 

Halson SL, Lastella M. Amazing athletes with ordinary habits: why is changing behavior so difficult? Int J Sports Physiol Perform 2017; 12:1273–5.

30 

Purcell R, Pilkington V, Carberry S, et al. An Evidence-Informed Framework to Promote Mental Wellbeing in Elite Sport. Front Psychol 2022; 13:780359. doi:10.3389/fpsyg.2022.780359

31 

Morente-Sánchez J, Zandonai T, Mateo-March M, et al. Acute effect of Snus on physical performance and perceived cognitive load on amateur footballers. Scand J Med Sci Sports 2015; 25:e423–31.

32 

Tabben M, Verhagen E, Warsen M, et al. Obstacles and opportunities for injury prevention in professional football in Qatar: exploring the implementation reality. BMJ Open Sport Exerc Med 2023; 9:e001370. doi:10.1136/bmjsem-2022-001370

Copyright: Institute of Sport. This is an Open Access article distributed under the terms of the Creative Commons CC BY License (https://creativecommons.org/licenses/by/4.0/). This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.